These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 4672983)

  • 1. The combined effects of x-rays and cell-borne immunity on cells of the C3H mouse tumour BP8, studied in vitro by a terminal dilution technique.
    Munro TR; Porteous DD
    Br J Radiol; 1972 Oct; 45(538):793. PubMed ID: 4672983
    [No Abstract]   [Full Text] [Related]  

  • 2. Combined cytolytic effect of x irradiation and cell-mediated immune reactions on tumor cells in vitro.
    Song CW; Levitt SH
    Radiology; 1974 Apr; 111(1):211-2. PubMed ID: 4205812
    [No Abstract]   [Full Text] [Related]  

  • 3. Role of macrophages in tumour immunity. I. Co-operation between macrophages and lymphoid cells in syngeneic tumour immunity.
    Evans R; Alexander P
    Immunology; 1972 Oct; 23(4):615-26. PubMed ID: 5084104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Possible involvement of immunologic factors in radiotherapy of mouse MM46 tumors (1). Modifying effects of radiation response using cyclophosphamide].
    Kunugita N; Dohi S; Norimura T; Tsuchiya T
    Nihon Igaku Hoshasen Gakkai Zasshi; 1988 Nov; 48(11):1459-66. PubMed ID: 3237470
    [No Abstract]   [Full Text] [Related]  

  • 5. Proceedings: Are the combined effects of X-ray and immune responses on cells unexpectedly lethal?
    Munro TR
    Br J Radiol; 1975 May; 48(569):414. PubMed ID: 1139108
    [No Abstract]   [Full Text] [Related]  

  • 6. [Role of immunologic activity of host in radiotherapy].
    Tsuchiya T
    Gan No Rinsho; 1983 Oct; 29(13):1499-505. PubMed ID: 6608014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of cell-mediated antiviral immunity and macrophage activation in C3H/HeN mice infected with mouse mammary tumor virus.
    Tagliabue A; Boraschi D; McCoy JL
    J Immunol; 1980 May; 124(5):2203-8. PubMed ID: 6245137
    [No Abstract]   [Full Text] [Related]  

  • 8. Role of macrophages in tumour immunity. II. Involvement of a macrophage cytophilic factor during syngeneic tumour growth inhibition.
    Evans R; Alexander P
    Immunology; 1972 Oct; 23(4):627-36. PubMed ID: 4563478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variation in histocompatibility antigen expression on murine tumors: differences in expression and immunogenicity of H-2K region-coded unique antigens.
    Imamura M; Martin WJ
    J Immunol; 1982 Aug; 129(2):877-81. PubMed ID: 7086147
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of localized radiotherapy upon the cellular immune response.
    Gerber M; Dubois JB; Pioch Y; Serrou B
    Radiat Res; 1981 Feb; 85(2):390-8. PubMed ID: 7465789
    [No Abstract]   [Full Text] [Related]  

  • 11. In vitro sensitization and induction of syngeneic tumor--specific cell--mediated cytotoxicity.
    Ferguson RM; Moe M; Simmons RL
    Surg Forum; 1976; 27(62):117-9. PubMed ID: 1032910
    [No Abstract]   [Full Text] [Related]  

  • 12. Depression of alloantigens in malignancy. Evidence for tumour susceptibility alloantigens and for possible self-reactivity of lymphoid cells active in the microcytotoxicity assay.
    Martin WJ; Esber E; Cotton WG; Rice JM
    Br J Cancer Suppl; 1973 Aug; 1():48-61. PubMed ID: 4804290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell-mediated immune responses to syngeneic ultraviolet-induced tumours. V. Assessment of accessory and antigen-presenting cell capabilities of normal and ultraviolet-irradiated mice in the generation of anti-tumour cytotoxic effector cells in vitro.
    Lynch DH; Gurish MF; Daynes RA
    Immunology; 1982 Sep; 47(1):49-59. PubMed ID: 6981587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A study of methods for producing cell-free tumour antigen from BP8 mouse ascites tumour.
    Davies EG; Cater DB
    Br J Exp Pathol; 1973 Oct; 54(5):583-9. PubMed ID: 4758387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Variations of cellular type specific immunological defense mechanisms as a function of tumor growth].
    Barski G; Youn JK; Belehradek J; Le François D
    Ann Inst Pasteur (Paris); 1972 Apr; 122(4):633-43. PubMed ID: 5050873
    [No Abstract]   [Full Text] [Related]  

  • 16. Humoral and cellular immune factors in the systemic control of artifically induced metastases in C3Hf mice.
    Vaage J
    Cancer Res; 1973 Aug; 33(8):1957-65. PubMed ID: 4720805
    [No Abstract]   [Full Text] [Related]  

  • 17. Evolution of cell-mediated immunity in mice bearing tumors produced by a mammary carcinoma cell line. Influence of tumor growth, surgical removal, and treatment with irradiated tumor cells.
    Le François D; Youn JK; Belehradek J; Barski G
    J Natl Cancer Inst; 1971 May; 46(5):981-7. PubMed ID: 5157849
    [No Abstract]   [Full Text] [Related]  

  • 18. [Cytotoxic immunity indices of melanoma B16 growth in mice].
    Korosteleva TA; Veresova OV
    Vopr Onkol; 1980; 26(1):67-70. PubMed ID: 7355591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of spleen cells on cytotoxicity by immune lymph node cells: cell-mediated immune suppression (? enhancement) in vitro.
    Klein WJ
    J Immunol; 1972 Jul; 109(1):51-8. PubMed ID: 5035245
    [No Abstract]   [Full Text] [Related]  

  • 20. Association of tumor and histocompatibility antigens in sera of lymphoma-bearing mice.
    Fujimoto S; Chen CH; Sabbadini E; Sehon AH
    J Immunol; 1973 Oct; 111(4):1093-100. PubMed ID: 4728678
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.